The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector

Simona Gamba

No 6004, CESifo Working Paper Series from CESifo

Abstract: This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for their distribution, count data models are used. A Zero Inated Negative Binomial model is adopted to consider the choice not to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries is roughly half of that for developed countries.

Keywords: intellectual property rights; developing countries; pharmaceutical sector; innovation; patents; TRIPS (search for similar items in EconPapers)
JEL-codes: I18 K11 O31 O34 (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.cesifo.org/DocDL/cesifo1_wp6004.pdf (application/pdf)

Related works:
Journal Article: The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector (2017)
Working Paper: The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector (2016)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ces:ceswps:_6004

Access Statistics for this paper

More papers in CESifo Working Paper Series from CESifo Contact information at EDIRC.
Bibliographic data for series maintained by Klaus Wohlrabe ().